Eli Lilly (LLY) Debt to Equity (2009 - 2026)

Eli Lilly (LLY) posted Debt to Equity of $1.39 for Q1 2026, down 13.21% quarter-over-quarter from $1.6 in Q4 2025, and up 107.88% year-on-year from $0.67 in Q1 2025.

Eli Lilly (LLY) Debt to Equity (2009 - 2026) Analysis & Trends

Eli Lilly (LLY) has reported Debt to Equity for 18 consecutive years, with $1.39 the latest figure, recorded in Q1 2026.

  • Debt to Equity for Q1 2026 came in at $1.39, up 107.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.39 (up 107.88% YoY), and the FY2025 annual result was $1.6, down 98.83% from the prior year.
  • Debt to Equity was $1.39 for Q1 2026 at Eli Lilly, down from $1.6 in the prior quarter.
  • Over five years, Debt to Equity peaked at $393.09 in Q2 2024 and troughed at -$720.29 in Q2 2025.
  • Average Debt to Equity over 5 years is -$31.21, with a median of -$3.92 recorded in 2022.
  • Year-over-year, Debt to Equity soared 4690.01% in 2022 and sank 12017.71% in 2023.
  • Over 5 years, Debt to Equity stood at $178.45 in 2022, then plunged by 104.69% to -$8.37 in 2023, then surged by 1733.56% to $136.76 in 2024, then sank by 98.83% to $1.6 in 2025, then fell by 13.21% to $1.39 in 2026.
  • Per Business Quant data, the three most recent Debt to Equity figures were $1.39 in Q1 2026, $1.6 in Q4 2025, and $1.78 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 1.39
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 0.68
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -9.70
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 1.07
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 6.24
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 0.94
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 0.72
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.39
Dec 31, 2025 1.60
Sep 30, 2025 1.78
Jun 30, 2025 -720.29
Mar 31, 2025 -17.65
Dec 31, 2024 136.76
Sep 30, 2024 -16.52
Jun 30, 2024 393.09
Mar 31, 2024 -6.10
Dec 31, 2023 -8.37
Sep 30, 2023 -448.18
Jun 30, 2023 -9.98
Mar 31, 2023 -5.00
Dec 31, 2022 178.45
Sep 30, 2022 -3.70
Jun 30, 2022 -3.92
Mar 31, 2022 -3.91
Dec 31, 2021 -3.89
Sep 30, 2021 -3.83
Jun 30, 2021 1.94